RFP - 2-PAM Autoinjectors for Project Bioshield (PBS) 75A50126R00002
Summary
AI-generated · Jun 17, 2026Late-stage clinical development and regulatory approval for 2-PAM autoinjectors, packaged as a drug/device combination, to treat organophosphate poisoning—including nerve agents—in both adult and pediatric populations.
Procurement of 2-PAM autoinjectors for the SNS/CHEMPACK program (stockpile emergency preparedness).
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
From Solicitation posted on Jun 16, 2026BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
From Solicitation posted on Jul 06, 2026BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
From Solicitation posted on Jul 08, 2026Notice history
3-
Solicitation Posted Jun 16, 2026
-
Solicitation Posted Jul 06, 2026No changes from previous notice
-
Solicitation LATEST Posted Jul 08, 2026No changes from previous notice
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA